Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Issue of Equity

28 Nov 2017 15:50

RNS Number : 7652X
CATCo Reinsurance Opps Fund Ltd
28 November 2017
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL OR TO U.S. PERSONS.

 

CATCo Reinsurance Opportunities Fund Ltd.

 

Result of Equity Issue

 

To: Specialist Fund Segment, London Stock Exchange and Bermuda Stock Exchange

Date: 28 November 2017

 

Following its announcement on 8 November 2017, the Company is pleased to announce that it has received applications and commitments for a total of 543,000,000 new C Shares pursuant to the Initial Placing and Offer at the price of US$1 per share, raising gross proceeds of US$543,000,000. Accordingly applications under the Offer and commitments under the Initial Placing will all be met in full. The Company received commitments for a total of 528,845,098 C Shares through the Initial Placing and applications for a total of 14,154,902 C Shares through the Offer.

 

Application has been made for 543,000,000 C Shares to be issued pursuant to the Initial Placing and Offer to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange. It is expected that Admission will become effective, and dealings will commence, at 8:00am (London time) on 1 December 2017.

 

Following Admission, the number of Ordinary Shares that the Company has in issue will be 934,666,430 and the number of C Shares that the Company has in issue will be 543,000,000. The C Shares carry the right to attend or vote at any general meeting of the Company in the same manner as the Ordinary Shares. Accordingly, the total number of voting rights in the Company will be 934,666,430 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

The Company will instruct Euroclear on or around 1 December 2017 (or as soon as practicable thereafter) to credit the appropriate stock accounts in CREST of the placees and subscribers (on a delivery versus payment basis) with their respective entitlements to Depositary Interests in respect of C Shares. Temporary documents of title will not be issued pending the dispatch by post of definitive certificates for C Shares in certificated form, which is expected to take place in the week commencing 11 December 2017.

 

Tony Belisle, Chief Executive, Markel CATCo Investment Management Ltd., said:

 

"We are delighted with the tremendous support shown by existing and new investors for Markel CATCo's specialised ILS investment opportunity. The fundraise will ensure the Company continues to meet the growing demand from our buyers for our unique reinsurance protections."

 

For further information, please contact:

 

Judith Wynne, General Counsel

 

Mobile: +44 (0) 7986 205364

 

Telephone: +1 (441) 493 9005

 

Email: judith.wynne@markelcatco.com

Mark Way, Chief Operating Officer

Mobile: +1 (441) 504 9178

Telephone: +1 (441) 493 900

Email: mark.way@markelcatco.com

 

 

Numis Securities Limited

Hugh Jonathan / Harry Trueman

Telephone: +44 (0) 20 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEVLFLDFFZFBL
Date   Source Headline
18th Dec 20241:48 pmRNSResult of Meeting
18th Dec 20247:30 amRNSSuspension - CATCo Reinsurance Opps Fund Ltd
18th Dec 20247:00 amRNS3rd Quarter Results
22nd Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
18th Nov 20247:00 amRNSCirc re. Proposed winding up and notice of SGM
13th Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
29th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
27th Sep 20243:05 pmRNSHalf-year Report
4th Sep 20247:00 amRNSNet Asset Value(s)
10th Jun 20247:00 amRNSNet Asset Value(s)
5th Jun 20242:21 pmRNSResult of AGM
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.